Pinned Tweet
Check out our review of the changes in the staging of cutaneous melanoma in the 8th edition of the AJCC, as well as pitfalls in histologic examination of staging parameters: bit.ly/melanomaAJCC8th
Anyone here attending the International Society of Dermatopathology joint meeting in Denver, Colorado this March? 馃槄 Also looking for suggestions for places to stay in, and also places to see!
Hello everyone! To pathologists here, what is the best whole slide image viewer (like Aperio ImageScope) for Mac? It seems we can only install ImageScope on Windows, and we are looking for an equivalent. Thank you! 馃槉
Hello, first post in quite a while! Anyone also attending the 1st international congress of the Korean Society of Pathologists? 馃槉 I am quite shy in person ahaha but would try my best to say hi if some of you are also here!
Celestine Trinidad, MD retweeted
Overseen today @UMMC in the #cytology area
Happy Valentine's day #pathtwitter
Celestine Trinidad, MD retweeted
EWSR1-NFATC2鈥攁ssociated sarcoma. NB: a very rare neoplasm, predominating in bone; anatomizing cords-to-sheets of small-to-medium cells; abundant myxohyaline stroma; RNA-seq useful in differentiating from potential mimics (Ewing sarcoma, myoepithelial tumour, &c).
Celestine Trinidad, MD retweeted
Spitz series 4/5 from the consult files of @melanopath
Multinucleated melanocytes, with moderate atypia, arranged in a sheet-like growth pattern in this MAP3K8-fused Spitz tumor #dermpath #dermatology
Celestine Trinidad, MD retweeted
鈿曪笍Femur, adult male
#BSTpath #Endopath #GUpath #Pathtwitter #Pathresident
鉃★笍Ill be posting less in the next few months for family reasons.
Hello, PathTwitter! I have not been posting going here recently because of new work responsibilities last year, but this year one of the goals is to get back to doing things I actually like doing, such as learning from everyone here. Hope we have a good year ahead! 馃槉
Celestine Trinidad, MD retweeted
As much as I love first-generation neuroendocrine markers, one must be aware of pitfalls when assessing lesions with focal/diffuse synaptophysin immunoreactivity. Several non-neuroendocrine tumors may express this marker, so confirmation with additional stains = YES. An example:
Celestine Trinidad, MD retweeted
"The wait is finally over". TBSRTC 2023 (3rd Ed) is now available for download as an e-book. The print version will be out soon. A big thanks to the four associate editors and all the chapter authors for their dedication and commitment to this most important work.
Syed and Paul
Celestine Trinidad, MD retweeted
Sonic Hedgehog (SHH) signaling pathway... SHH binds PTCH1, leading to release of SMO (Smoothened), altering transcription and cell growth.
Mutations in the pathway are involved in birth defects, basal cell carcinoma, Gorlin Syndrome, medulloblastoma, & other tumors.
Celestine Trinidad, MD retweeted
Who knew blueberries could teach us about healthy cells? 馃珢馃槻. Today鈥檚 #IntroToPath, I use 'em to explain metaplasia (馃枻 blackberries), hyperplasia, and hypertrophy 馃挭馃徑. It's like a berry-licious journey through the world of pathology! 馃寧#Path4People #BerriesForEducation 馃崜馃崚馃敩
Celestine Trinidad, MD retweeted
#PathArt Sneak Peek#2 Enjoy these beautiful entries by our super talented and creative residents, fellows and faculty!
Celestine Trinidad, MD retweeted
馃ΥDedifferentiated chondrosarcoma.馃Υ
Left: high grade noncartilaginous sarcoma / Right: conventional chondrosarcoma.
#Pathology #AnatomiaPatologica #Pathologyst
#BSTpath
#PathTwitter
So lovely to meet you in person, Dr. Maclean! I hope you enjoyed your stay here (and hope to see you again!) 馃槉
#PSP2023 #PhilippineSocietyofPathology
What a great meeting! Thanks for inviting me - I鈥檓 having a great time. @LuisBlancoJrMD @aremaley1 @celestrinmd






































